UFP Technologies Inc. - Form 8-K Summary
Business Context and Reporting Period
Company: UFP Technologies, Inc.
Filing Date: February 19, 2026
Reporting Period: Current Report (Event Date: February 19, 2026)
Context: The Company entered into Amendment No. 27 to its Manufacturing Supply Agreement with Intuitive Surgical SARL, a strategic medical customer. The original agreement was dated April 25, 2014.
Key Financial Metrics
This filing is a Current Report (Form 8-K) regarding a material definitive agreement and does not contain financial statements, revenue figures, profit data, cash flow, margins, debt levels, or liquidity metrics. The filing text does not provide a clear value for any financial performance indicators.
Material Changes and Agreement Details
Effective January 1, 2026, the Amendment to the Supply Agreement includes the following material changes:
- Term Extension: The agreement term is extended by two additional years, now running through December 31, 2029.
- Volume Increases: Annual minimum volumes for the largest program are materially increased for the years 2028 and 2029.
- New Program: An additional program has been added to the Supply Agreement.
- Pricing Structure: Implementation of volume-based pricing tied to minimum purchase thresholds and new cost-sharing provisions.
Guidance, Outlook, and Risks
Management Commentary: The filing includes standard forward-looking statements regarding expected revenue and performance under the agreement. The Company disclaims any obligation to update these statements.
Risks and Contingencies: The filing highlights several risks that could cause actual results to differ from expectations:
- Customer Demand: Risk that Intuitive Surgical will not purchase expected volumes due to reduced product requirements, performance issues, or a decision to manufacture the product internally or via affiliates.
- Supplier Competition: Risk that the customer obtains the product from other listed suppliers in the agreement.
- Operational Capacity: Risks related to maintaining increased production levels profitably and increasing production rates.
- Supply Chain: Potential disruptions and delays in the supply chain or labor force.
Investor Verification Checklist
- Verify the specific volume increases and pricing thresholds in the full text of Amendment No. 27 (Exhibit 10.1), noting that certain competitively sensitive information was redacted.
- Review the Company's most recent Form 10-K and 10-Q for historical financial performance and capacity constraints.
- Assess the concentration risk associated with Intuitive Surgical SARL as a strategic customer.
- Monitor future filings for updates on the execution of the new program and the ability to meet the increased minimum volumes for 2028 and 2029.